NEUROCRINE BIOSCIENCES INC·4

Feb 23, 7:12 PM ET

Onyia Jude 4

4 · NEUROCRINE BIOSCIENCES INC · Filed Feb 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Neurocrine Biosciences (NBIX) CSO Onyia Jude Gifts 3,110 Shares

What Happened Onyia Jude, Chief Scientific Officer of Neurocrine Biosciences (NBIX), made a disposition by gift of 3,110 shares on February 20, 2026. The Form 4 reports this as a gift transaction (code G) with a reported price of $0.00 and $0 proceeds — the shares were transferred as a charitable/gift contribution rather than sold on the market.

Key Details

  • Transaction date: February 20, 2026 (reported on Form 4 filed Feb 23, 2026).
  • Transaction type/code: Gift (G); reported price $0.00; proceeds reported $0.
  • Shares transferred: 3,110 common shares.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnote: F1 states this was a gift/charitable contribution effective Feb 20, 2026; not a market transaction and no value was received for the gifted shares.
  • Filing timeliness: Form 4 was filed Feb 23, 2026 (appears to be within the normal reporting window).

Context Gifts by insiders are reported as dispositions but do not represent open-market sales and generally do not indicate the insider's view on the company’s stock price. Such transfers are often for personal or charitable reasons; no cash changed hands in this reported transaction.

Insider Transaction Report

Form 4
Period: 2026-02-20
Onyia Jude
Chief Scientific Officer
Transactions
  • Gift

    Common Stock

    [F1]
    2026-02-203,11025,670 total
Footnotes (1)
  • [F1]This transaction represents a gift/charitable contribution effective February 20, 2026. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.
Signature
/s/ Darin Lippoldt, Attorney-in-Fact|2026-02-23

Documents

1 file
  • 4
    wk-form4_1771891938.xmlPrimary

    FORM 4